Finding the best prices at pharmacies near you...

Blog

CDC: Less than one-quarter of American adults get enough exercise

Less than one-quarter of Americans get the government-recommended amount of exercise, according to an annual health survey published by the Centers for Disease Control and Prevention (CDC).  The National Health Statistics Report examined responses to an annual survey and found only 23 percent...

Read More

Get Ready for Summer! FDA highlights importance of sunscreen

Americans have been urged to take precautions to protect against ultraviolet (UV) radiation and skin cancer during the hotter months of the year. In a statement issued by the US Food and Drug Administration (FDA), FDA Commissioner Scott Gottlieb, MD, highlighted the dangers and prevalence of skin...

Read More

First biosimilar to cancer drug Neulasta approved by FDA

Fulphila (pegfilgrastim-jmdb) is the first biosimilar to Neulasta (pegfilgrastim) to gain approval from the US Food and Drug Administration (FDA). The Mylan GmbH medicine was approved as a treatment to reduce the risk of infection as suggested by febrile neutropenia (fever caused by a lack of...

Read More

ACS: Colorectal cancer screening 'should start at age 45'

The average American should start regular colorectal cancer screenings at the age of 45, according to new guidelines issued by the American Cancer Society (ACS). Previous recommendations from the organization suggested people at average risk of the condition should begin a screening schedule at the...

Read More

CDC warns about infection risk in hotel pools and hot tubs

One in three waterborne disease outbreaks in the United States between 2000 and 2014 occurred in hotel pools and hot tubs, according to recent findings published by the Centers for Disease Control and Prevention (CDC). The  Morbidity and Mortality Weekly Report found more than half the...

Read More

Trump unveils blueprint for lowering prescription drug prices

President Donald Trump has unveiled a “blueprint” to lower the price of prescription drugs in the United States. The plans include building on the existing administrative efforts of the US Food and Drug Administration (FDA) to increase generic drug approvals, reforms to the Medicare...

Read More

Tagrisso approved as first-line treatment for metastatic NSCLC

The US Food and Drug Administration (FDA) has approved the protein kinase inhibitor Tagrisso (osimertinib) as a first-line treatment option for certain patients with metastatic non-small cell lung carcinoma (NSCLC). Earlier this month, AstraZeneca presented new data from a Phase III FLAURA trial...

Read More